Status:
COMPLETED
Serum 1,25-dihydroxyvitamin D Levels in Type 2 Diabetes Mellitus Patients With Different Levels of Albuminuria
Lead Sponsor:
Tianjin Medical University General Hospital
Conditions:
Type 2 Diabetes Mellitus With Diabetic Nephropathy
Eligibility:
All Genders
18-80 years
Brief Summary
Diabetic nephropathy(DN)is a major microvascular complication of diabetes.Renal injury may be presented with the characteristics of albuminuria, and its main pathological change is glomerular sclerosi...
Eligibility Criteria
Inclusion
- age \>18 years, DM duration \>1 year, all of the patients were predialysis
Exclusion
- history of liver or kidney disease, malignancy, current pregnancy, extensive dermatologic disease, evidence of metabolic bone disease and hyper-/hypo- thyroidism that would affect mineral metabolism. Patients who were taking native or active vitamin D, steroids, phosphate binders, or medications that affect vitamin D metabolism were also excluded.
Key Trial Info
Start Date :
February 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT01845870
Start Date
February 1 2012
End Date
April 1 2013
Last Update
June 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, China, 300052